Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Autolus

Autolus
2014 FOUNDED
PUBLIC STATUS
101-200 EMPLOYEES
AUTL STOCK SYMBOL
$13.80 SHARE PRICE (As of Wednesday Closing)
Description

Autolus Therapeutics PLC is a biopharmaceutical company. It is engaged in the development of next-generation programmed T cell therapies for the treatment of cancer. The company's pipeline includes AUTO1, AUTO2, AUTO3, AUTO4, and others.

Website
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Stock Exchange
NAS
Primary Office
  • The Mediaworks, 191 Wood Lane
  • White City
  • London W12 7RZ
  • England, United Kingdom

+44 020 0000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Autolus’s full profile, request a free trial.

Autolus Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$9.50 - $49.50 $621M $12.69 -$2.47 286K 45M

Autolus Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2018
30-Sep-2018
FY 2017
30-Sep-2017
FY 2016
30-Sep-2016
Enterprise Value 319,903 1,110,847
Revenue 2,895 1,407 1,693 1,212
EBITDA (116,269) (51,854) (22,455) (13,924)
Net Income (103,553) (44,751) (19,727) (12,550)
Total Assets 314,641 273,205 148,662 34,180
Total Debt 26,689
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Autolus Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Autolus‘s full profile, request access.

Request full access to PitchBook

Autolus Competitors (72)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Renova Therapeutics Venture Capital-Backed San Diego, CA 000.00 00000000000 000.00
000000000 Private Equity-Backed Gaithersburg, MD 000.00 0000000 0000 000.00
000 000000000 Corporation Gainesville, FL 0 00.000 000000000000 00.000
0000 000000000000 Formerly VC-backed Cambridge, MA 00 00000 00000000 00000
00000 000000000 Formerly VC-backed South San Francisco, CA 000 00000 00000000 00000
To view this company’s complete list of competitors, request access »

Autolus Executive Team (13)

Name Title Board
Seat
Contact
Info
Christian Itin Ph.D Chief Executive Officer & Chairman
Andrew Oakley Chief Financial Officer & Senior Vice President
Christopher Vann Chief Operating Officer & Senior Vice President
Martin Pule Founder, Board Member, Senior Vice President & Chief Scientific Officer
Chris Williams Ph.D Director, Business Development & Board Member
You’re viewing 5 of 13 executives. Get the full list »

Autolus Board Members (10)

Name Representing Role Since Contact
Info
Chris Williams Ph.D Autolus Director, Business Development & Board Member 000 0000
Christian Itin Ph.D Autolus Chief Executive Officer & Chairman 000 0000
Cynthia Butitta Autolus Board Member 000 0000
John Berriman Self Board Member 000 0000
Joseph Anderson Ph.D Arix Bioscience Board Member 000 0000

1 Former Board Member

You’re viewing 5 of 10 board members. Get the full list »